The hypothalamus is a critical regulator of many physiological processes essential for life. In the adult brain, each anatomically-defined hypothalamic nucleus consists of functionally heterogeneous neuronal subpopulations that dictate distinct survival behaviors. Nevertheless, how rich neuronal identities are established in the developing hypothalamus remains poorly understood.
Serving as the interface between the nervous and endocrine systems, the hypothalamus is a critical regulator of many physiological processes essential for life. Recent advances in optogenetic, chemogenetic, and imaging techniques have enabled the isolation of individual hypothalamic circuits that control satiety 1 , thirst 2 , aggression 3 , and many more. These studies further demonstrate that each anatomically-defined hypothalamic nucleus consists of functionally heterogeneous neuronal subtypes that dictate distinct survival behaviors. On the other hand, how rich neuronal identities are established in the developing hypothalamus remains poorly understood 4 .
Within the ARH, earlier studies have uncovered a transcriptional cascade that sequentially specifies postmitotic neuronal precursors [5] [6] [7] [8] . However, the mechanism whereby common neuronal precursors subsequently adopt either the anorexigenic (POMC) or the orexigenic (NPY/AgRP) identity remains elusive. While fate specification has been thoroughly investigated in other parts of the nervous system, it remains an understudied subject in the hypothalamus. For example, the dynamic expression patterns of peptidergic markers make it difficult to track POMC and NPY/AgRP neurons during development 9 . Moreover, since cell bodies of these neurons are closely intermingled with each other, existing databases on gene expression (e.g. Genepaint and Allen Brain Library) offer few clues for celltype-specific transcripts behind fate choices. To overcome these hurdles, we purified geneticallylabeled POMC and NPY/AgRP from the developing mouse hypothalamus and profiled their transcriptomes using whole-genome RNA sequencing.
To track developing POMC and NPY/AgRP neurons, we took advantage of two wellcharacterized transgenic mice (POMC eGFP and NPY hrGFP ) in which POMC and NPY/AgRP neurons are genetically labeled by the expression of green fluorescent proteins 10, 11 . Despite a shared birthdate 9 , POMC and NPY/AgRP neurons launch their peptidergic marker expression at distinct developmental periods. Pomc mRNA first appears in the hypothalamic ventricular zone at embryonic (E) day E10.5 6 . It is transiently expressed in other neurons before being committed to prospective POMC neurons after E14.5 12 . In comparison, Npy mRNA is not present in the presumptive ARH until E13.5 9 . Consistent with endogenous Pomc and Npy, we observed the onset of POMC-eGFP and NPY-hrGFP expression at E10.5 and E13.5 respectively in the developing ARH ( Supplementary Fig. 1a-b ). Although NPY/AgRP neurons co-express NPY and AgRP in the adult brain 13 , it has been reported that the onset of Agrp expression within NPY/AgRP neurons did not occur until perinatally 14 . Using AgRP-iresCre activity as a surrogate for endogenous Agrp expression 15 , we detected the expression of Cre-activated tomato reporter (Rosa26 Ai14 ) in only a few ARH neurons as early as E15.5 ( Supplementary Fig. 1c ).
The number of tomato positive neurons gradually increases over time, and by postnatal day 7 (P7), reporter expression is found only in a subset of NPY-hrGFP neurons ( Supplementary Fig. 1d ). Therefore, our finding supports the notion that the acquisition of the AgRP identity spans an extended postnatal period.
To uncover the intrinsic factors underlying the anorexigenic vs. the orexigenic identity, we profiled the transcriptomes of developing POMC and NPY/AgRP neurons at E15.5 while they were acquiring their adult neurotransmitter identities. Under a fluorescent dissecting microscope, we dissociated the ARH from POMC eGFP or NPY hrGFP embryos and purified GFP positive neurons through fluorescence-activated cell sorting (FACS, Fig. 1a ). We collected 3-4 biological replicates per genotype.
Each biological replicate was defined as an independent sort from pooled embryos from different litters.
We extracted total RNAs from approximately five-thousand to ten-thousand neurons per replicate and subjected them to whole-transcriptome RNA sequencing (Illumina HiSeq TM 2500). We obtained an average of 77.8 million mapped reads/sample. Reads were aligned to the mouse reference genome GRCm38/mm10 assembly using HISAT2 16 . From there, we detected 10317 genes present in at least one of the two populations with a minimum expression of 10 transcripts per million mapped reads (TPM, Supplementary Table 1 ).
Our analysis identified 120 differentially expressed genes (DEGs) between POMC and NPY/AgRP neurons at E15.5 (Supplementary Table 2 and see 'Materials and methods' for criteria). As expected, transcripts for Pomc and Npy were highly enriched in POMC and NPY/AgRP neurons respectively ( Fig. 1b ). In contrast, Cart and Agrp whose expression comes on late during development were barely detectable at this stage. Other than the peptidergic markers, we found an enrichment of 17 . We compared the embryonic and adult datasets using multidimensional scaling analyses and found a clear separation in gene expression patterns of the same neurons ( Fig.   1c ). For example, adult POMC and NPY/AgRP express receptors for multiple metabolic hormones such as leptin, insulin, ghrelin, and serotonin. However, most of these receptors-except for the insulin receptor and the cannabinoid receptor 1-were expressed at very low levels (between 0 and 6.3 TPM) at E15.5 (Fig. 1d ). Along the same line, pathway analyses revealed an enrichment of genes involved in G-protein coupled receptor signaling, endoplasmic reticulum stress and circadian rhythm in adult POMC and NPY/AgRP neurons 17 . In contrast, those involved in neuronal growth, differentiation, and axon development ( Fig. 1e -f, Supplementary Table 3 ) were overrepresented at E15.5. Collectively, these findings demonstrate that developing POMC and NPY/AgRP neurons possess distinct transcription profiles compared to their adult counterparts.
We focused our analyses on transcription factors (TFs) as they play a critical role in neuronal differentiation and fate specification. We detected transcripts of 1106 TFs in either POMC or NPY/AgRP neurons at E15.5 ( Supplementary Table 4 ). While the vast majority of these factors were present at equivalent levels in both neurons, 29 of them showed differential enrichment in one of the two groups ( Fig. 2a ). As expected, the basic helix-loop-helix factor Nhlh2 is enriched in POMC neurons and controls the levels of prohormone convertase I (Pcsk1), the enzyme that converts POMC to α-MSH 18 . Moreover, TFs such as Nkx2.1, Tbx3, Dlx1, and Dlx2 are initially expressed in a broad domain of progenitors during early differentiation 5, 19, 20 . We found that their expression persists in postmitotic neurons and are selectively enriched in either POMC (Nkx2.1 and Tbx3) or NPY/AgRP (Dlx1 and Dlx2) neurons ( Fig. 2a-c) . These findings are consistent with recent reports that these factors continue to play a role in POMC or NPY/AgRP neurons after neurogenesis [21] [22] [23] .
In addition to the TFs that have an established role, our analyses identified many TFs that have yet been implicated in the development of ARH neurons. Particularly, the establishment and maintenance of the anorexigenic POMC neuron identity is highly relevant to childhood obesity as mutations in Pomc cause severe early-onset obesity in humans 24 . However, genetic factors that regulate Pomc expression remain largely unknown. We found several members of the Sox proteins (Sox1, Sox2, Sox3, and Sox14) were enriched in POMC neurons ( Fig. 2a ). de Souza et al. previously characterized upstream enhancer elements (nPE1 and nPE2) that were both necessary and sufficient to drive reporter gene expression in hypothalamic POMC neurons 25 . Analyses of these sequences revealed several conserved Sox binding sites across multiple mammalian species ( Supplementary Fig.   2 ). These findings, therefore, raise the possibility that Sox proteins may directly interact with upstream enhancer sequences to regulate Pomc transcription. Moreover, we found that developing POMC neurons, but not NPY/AgRP neurons, express mRNAs and proteins of the transcription factor 7-like 2 (Tcf7l2, Fig2. a, d, e). Polymorphisms of Tcf7l2 are among the most significant genetic markers associated with type 2 diabetes across multiple ethnic groups 26 . Previous studies largely focused on its role in peripheral organs such as the pancreatic islets and the liver 27 . However, given the importance of POMC neurons in coordinating glucose metabolism 28 , it is possible that these neurons may serve as a critical node where Tcf7l2 programs glucose homeostasis at critical developmental periods. Furthermore, the nuclear receptor Nr5a1 (also known as Steroidogenic factor 1, SF1) has been known as a selective marker for VMH neurons during development 29 . Its expression within the developing ARH, however, is controversial. While an earlier study reported Nr5a1 proteins in developing POMC neurons 6 , a subsequent analysis failed to corroborate this finding 30 . Using cell-type-specific RNA-seq, we detected Nr5a1 mRNAs in POMC neurons ( Fig. 2a, f) . In support of this finding, fate-mapping of SF1-Cre 31 expressing neurons revealed that a subset of adult POMC neurons (37.6% ± 5.5%) expresses the Cre-activated tomato reporter (Fig. 2g ). Since Nr5a1 is absent from adult POMC neurons 17 , our finding suggests that Nr5a1 is transiently expressed in POMC neurons during development.
However, a developmental role for Nr5a1 within POMC neurons remains to be determined. Furthermore, whether its expression demarcates a functionally-unique subset of POMC neurons warrants further investigations. Finally, our analyses uncovered an enrichment of two PR-domain containing factors Prdm12 and Prdm13 in developing POMC neurons ( Fig. 2a, h, i) . Both factors play an important role in lineage specification in the developing spinal cord [32] [33] [34] . However, whether these factors play a similar role in the hypothalamus has not been studied.
To test whether POMC-enriched TFs are necessary for the anorexigenic neuron identity, we turned to mouse genetics to interrogate their functions in vivo. We first targeted Prdm12 since it has not been implicated in the development of hypothalamic neurons nor in energy balance. Prior to the first appearance of Pomc, we detected Prdm12 mRNA in the ventral hypothalamic neuroepithelium at E9.5 (data not shown). Moreover, it is present within POMC neurons when they first emerge at E10.5 (Fig.   3a ). To investigate the physiological role of Prdm12 in vivo, we developed a conditional Prdm12 allele , Fig. 3b, d) .
Meanwhile, quantitative PCR (qPCR) analyses detected comparable levels of Prdm12 mRNAs within the hypothalamus between Prdm12 +/+ and Prdm12 fl/fl littermates, suggesting that the introduced loxP sites did not perturb endogenous Prdm12 transcription (Fig. 3e ). We bred POMC-Cre mice 35 with Prdm12 fl/fl mice to generate POMC-Cre; Prdm12 fl/fl mice in which Prdm12 was selectively deleted in embryonic POMC neurons (designated hereafter as Prdm12 POMCeKO mice). A Cre-dependent tdTomato reporter (Rosa26 Ai14 ) was used to mark POMC-Cre expressing neurons in Prdm12 POMCeKO mice as well as those in mice heterozygous for the floxed Prdm12 allele (POMC-Cre; Prdm12 fl/+ , Fig. 3f, g) . We verified the loss of Prdm12 mRNAs in FACS-sorted tdTomato+ neurons in Prdm12 POMCeKO mice (Fig.   3h ). Cell counting analyses found similar numbers of tdTomato+ cells present in the adult brains of both genotypes, suggesting that Prdm12 is dispensable for the survival of POMC neurons (Fig. 3i ).
Remarkably, in situ hybridization uncovered a significant loss of Pomc mRNAs in the ARH of Prdm12 POMCeKO mice (Fig. 3j, k) . In contrast, the expression of Npy and Agrp remained unaffected ( Fig.   3l-3o ). Importantly, immunohistochemistry for beta-endorphin, a proteolytic product of POMC, suggested that Pomc expression is not altered in the pituitary gland ( Fig. 3p-q) . Consistent with these findings, qPCR analyses confirmed a selective loss of Pomc transcripts among several genes known to be expressed in the ARH. Collectively, these findings suggested a hypothalamic Pomc deficiency in Prdm12 POMCeKO mice (Fig. 3r) .
POMC activates the downstream melanocortin 4 receptors (MC4R) to suppress appetite. Of note, genetic variants within the POMC/MC4R pathway are the most common obesity-causing mutations found in obese children 36 . We investigated whether Prdm12 POMCeKO mice manifested similar metabolic deficits observed in humans 37 . We found that Prdm12 POMCeKO mice had increased body weight at the time of weaning (Fig. 4a) . The excessive weight gain was further exacerbated by subsequent feeding with a high-fat diet (HFD, 60 kcal% fat, D12492i Research Diets, Fig. 4b ). Nuclear magnetic resonance imaging revealed that the elevated body weight was largely due to an increase in fat mass, along with a modest gain in lean mass (Fig. 4c ). In support of this finding, H&E staining revealed significantly increased lipid accumulation in both the white adipose tissue and liver of Prdm12 POMCeKO mice ( Supplementary Fig. 3 ). Moreover, consistent with an MC4R deficiency, we found that Prdm12 POMCeKO mice had an increased body length (nose to anus) compared with their littermate controls ( Fig. 4d ). To further unravel the physiological changes behind the excessive weight gain, we conducted metabolic chamber analyses using a new cohort of Prdm12 POMCeKO mice and their littermate controls. These mice had been maintained on a regular chow diet before entering the experiment at eight weeks of age. By that time, Prdm12 POMCeKO mice had increased fat mass (2.31±0.12g vs.
1.18±0.14g, p<0.001), but had comparable lean mass (20.61±0.59g vs. 20.48±0.47g, p=0.87). Mice were fed a chow diet during acclimation and the first three days of recording before being switched to an HFD for the next seven days. Under both diets, Prdm12 POMCeKO mice consumed more food during the dark phase of a day (Fig. 4e-f ). On the other hand, heat production was similar between chow-fed Prdm12 POMCeKO and control mice (Fig. 4g) . In contrast, heat production was significantly lower in Prdm12 POMCeKO mice during HFD exposure (Fig. 4h ). Collectively, these results suggest that the HFDinduced exacerbation of weight gain is the result of a combination of increased energy intake and reduced expenditure. Finally, concomitant with obesity were perturbations in glucose homeostasis. For example, Prdm12 POMCeKO mice showed a deficit in glucose clearance during a glucose tolerance test (GTT, Fig. 4l ). In control mice, plasma insulin levels elevated in response to the glucose challenge during the GTT. In contrast, insulin levels were significantly higher in Prdm12 POMCeKO mice at the baseline but did not increase during the GTT (Fig. 4j ). The impairment in insulin sensitivity was further confirmed using an insulin tolerance test (ITT, Fig. 4k ).
In summary, the combination of cell-type-specific transcriptomics and mouse genetics provided a means to dissect cellular and functional diversity in the developing hypothalamus and help better understand the developmental origins of hypothalamus-controlled survival behaviors. Transcriptomic profiling of developing POMC and NPY/AgRP neurons allowed us to decipher the transcriptional codes behind the orexigenic vs. anorexigenic identity. Moreover, it offers a resource for studying other developmental milestones (e.g. axon pathfinding, synapse formation) necessary for the assembly of melanocortin feeding circuits. Finally, our studies uncovered a previously unrecognized role for Prdm12 in Pomc transcription. Importantly, loss of Prdm12 in embryonic POMC neurons led to early-onset obesity, which is characteristic of human POMC/MC4R deficiency. Therefore, the discovery of Prdm12, along with other POMC-enriched TFs, helps identify new genetic factors behind the rising epidemic of childhood obesity. Sequences of mouse nPE1 (chr12:3941972-3942627, 656 bp) and nPE2 (chr12:3944600-3944917, 318 bp) defined by de Souza et al. were obtained using the ECR Genome Browser (https://ecrbrowser.dcode.org). Sequence alignment was conducted using the ConTra V3 web server (http://bioit2.irc.ugent.be/contra/v3/). Matrices used to predict Sox binding motifs include taipale-TCAATWNCATTGA-Sox1-DBD for Sox1, MA0143.3 for Sox2, M1592_1.02 for Sox3, and taipale-ACAATANCATTG-Sox14-DBD for Sox4 with the stringency setting (core=1.00, similarity matrix=0.95).
